Nilsu Çini

Nilsu Çini

Auto-generated profile, based on publicly available information

Nilsu Çini

Department of Radiation Oncology, Kartal Dr. Lutfi Kırdar City Hospital, İstanbul, Turkey

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2023 in Journal of Korean Neurosurgical Society
Verified
Journal Article
Open access
PDF file
GGGokhan GURKAN
Gokhan GURKAN
ÖAÖzüm Atasoy
Özüm Atasoy
NÇNilsu Çini
Nilsu Çini
ISİbRahim Halil Sever
İbRahim Halil Sever
BÖBahattin Özkul
Bahattin Özkul
OEOytun Erbaş
Oytun Erbaş
Objective : This animal model aimed to compare the rat group that received brain irradiation and did not receive additional treatment (only saline) and the rat group that underwent brain irradiation and received Granulocyte colony stimulating factor (G-CSF) treatment. In addition, the effects of G-CSF on brain functions were examined by magnetic resonance (MR) imaging and histopathologically.Methods : This study used 24 female Wistar albino rats. Drug administration (saline or G-CSF) was started at the beginning of the study and continued for 15 days after whole-brain radiotherapy (WBRT). WBRT was given on day 7 of the start of the study. At the end of 15 days, the behavioral tests, including the three-chamber sociability test, open field test, and passive avoidance learning test, were done. After the behavioral test, the animals performed the MR spectroscopy procedure. At the end of the study, cervical dislocation was applied to all animals.Results : G-CSF treatment positively affected the results of the three-chamber sociability test, open-space test and passive avoidance learning test, cornu Ammonis (CA) 1, CA3, and Purkinje neuron counts, and the brain levels of brain-derived neurotrophic factor and postsynaptic density protein-95. However, G-CSF treatment reduced the glial fibrillary acidic protein immunostaining index and brain levels of malondialdehyde, tumor necrosis factor-alpha, nuclear factor kappa-B, and lactate. In addition, on MR spectroscopy, G-CSF had a reversible effect on brain lactate levels.Conclusion : In this first designed brain irradiation animal model, which evaluated G-CSF effects, we observed that G-CSF had reparative, neuroprotective and anti-neurodegenerative effects and had increased neurotrophic factor expression, neuronal counts, and morphology changes. In addition, G-CSF had a proven lactate-lowering effect in MR spectroscopy and brain materials.

8 November 2019 in Strahlentherapie und Onkologie
Verified
Journal Article
Open access
PDF file
NCNilsu Cini
Nilsu Cini
SGSylvia Gruber
Sylvia Gruber
ZAZumre Arican Alicikus
Zumre Arican Alicikus
WDWolfgang Dörr
Wolfgang Dörr
Purpose: During head and neck cancer radiotherapy, oral mucositis is the most frequent early side effect. Systemic dermatan sulfate (DS) administration has been shown to significantly decrease oral mucosal radiation reactions during daily fractionated irradiation (IR) in an established mouse model. The aim of this study was to investigate the mechanism of the oral epithelial differentiation process, during IR alone and in combination with DS treatment in the same mouse model. Methods: Fractionated IR 5 × 3 Gy/week was given to the snouts of mice over two weeks, either alone (IR) or in combination with daily DS treatment of 4 mg/kg (IR + DS). Groups of mice (n = 3) were sacrificed every second day over the course of 14 days in both experimental arms. Their tongue was excised and subjected to immunohistochemical processing. Results: In the p16 analysis as a proliferation marker, the difference between IR alone and IR + DS in the germinal (proliferation) layer was not significant, not stimulating the proliferation process. For the p21 analysis as a differentiation marker on the functional (differentiation) layer, the difference between IR alone and IR + DS arms was significant, indicating that DS inhibited the differentiation process. In the cytokeratin (CK) analysis as the indicator of cellular skeletal integrity, the percentage of antibody-positive cells was above the normal level in both experimental arms and significantly superior in the IR + DS arm. Conclusion: The mucosal protective activity of DS, instead of stimulating proliferation, is based on prevention of cell loss by a combination of effects leading to the inhibition of cellular differentiation and an increase in the expression of epithelial mechanical strength between intercellular mechanical junctions.

12 May 2025 in Strahlentherapie und Onkologie
Verified
Journal Article
Closed access
PDF file
NCNilsu Cini
Nilsu Cini
ÖAÖzüm Atasoy
Özüm Atasoy
Yigit UyanıkgilYigit Uyanıkgil
Yigit Uyanıkgil
GYGökhan Yaprak
Gökhan Yaprak
MEMumin Alper Erdogan
Mumin Alper Erdogan
OEOytun Erbas
Oytun Erbas

27 July 2024 in Radiation and Environmental Biophysics
Verified
Journal Article
Closed access
PDF file
GYGökhan Yaprak
Gökhan Yaprak
NÇNilsu Çini
Nilsu Çini
ÖAÖzüm Atasoy
Özüm Atasoy
Yigit UyanıkgilYigit Uyanıkgil
Yigit Uyanıkgil
MEMumin Alper Erdogan
Mumin Alper Erdogan
OEOytun Erbaş
Oytun Erbaş

1 December 2021 in Demiroglu Science University Florence Nightingale Journal of Medicine
Verified
Journal Article
Open access
PDF file
MKMihrican Koçak
Mihrican Koçak
ÖAÖzüm Atasoy
Özüm Atasoy
NÇNilsu Çini
Nilsu Çini
OEOytun Erbaş
Oytun Erbaş
Glioblastoma is the most aggressive primary malignant brain tumor, also known as isocitrate dehydrogenase (IDH) wild-type gliomas. Symptoms vary depending on where the tumor is located. It is often manifested by headaches, epileptic seizures, and personality changes. Glioblastoma constitutes 15% of primary brain tumors and the reasons for its formation are still unclear. Primary treatment is surgery, followed by chemoradiotherapy. Although maximal surgical resection is standard, it often recurs. The vast majority of patients die within two years of diagnosis. In this study, we aimed to examine glioblastoma in detail with the treatment possibilities available today.

1 January 2025 in Turkish Journal of Oncology
Verified
Journal Article
Closed access
NÇNilsu Çi̇nİ
Nilsu Çi̇nİ
SASerhat Aras
Serhat Aras
ŞGŞule Karabulut Gül
Şule Karabulut Gül